Aemetis AMTX 深 滬
等待開盤 09-18 09:30:00 美东时间
2.18
-0.010
-0.46%
華盛通- 最 高2.38
- 今 開2.19
- 成交量 76.08万股
- 最 低 2.18
- 昨 收 2.19
- 總市值 1.21亿
- 52周最高 4.73
- 市盈率 靜 --
- 換手率 1.37%
- 52周最低 1.22
- 委 比 -37.50%
- 總股本 5536.94万
- 歷史最高 27.44
- 量 比 1.05
- 振 幅 9.13%
- 歷史最低 0.152
- 每 手 1
- 風險率 0.68%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Aemetis Signs Agreement with NPL Construction Co. for $30 Million Mechanical Vapor Recompression System at Keyes Ethanol Plant
Aemetis Inc. subsidiary Keyes plant has signed an EPC contract with NPL Construction Co. to install a Mechanical Vapor Recompression (MVR) system at its ethanol facility in California. The $30 million project, supported by $19.7 million in tax credits and grants, aims to reduce natural gas usage by 80%, generating $32 million in annual savings and enhancing carbon intensity credits. Expected completion is Q2 2026, aligning with Aemetis' strategy ...
09-09 12:00
Autonomix Medical, Inc. to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech
Autonomix Medical, Inc. will present at the Webull Financial Corporate Connect Webinar Series on August 21, 2025, at 2:20 PM ET. Brad Hauser, President and CEO, will deliver the presentation. The company focuses on advancing precision nerve-targeted treatments and innovative technologies for nervous system diseases. Investor contact details are provided.
08-15 13:00
Aemetis shares are trading lower after the company reported worse-than-expected Q2 financial results.
Aemetis shares are trading lower after the company reported worse-than-expected...
08-08 01:46
Aemetis Q2 EPS $(0.41) Misses $(0.30) Estimate, Sales $52.243M Miss $84.095M Estimate
Aemetis (NASDAQ:AMTX) reported quarterly losses of $(0.41) per share which missed the analyst consensus estimate of $(0.30) by 36.67 percent. This is a 37.88 percent increase over losses of $(0.66) per share from the
08-07 20:02
Earnings Scheduled For August 7, 2025
Companies Reporting Before The Bell • GoHealth (NASDAQ:GOCO) is estimated to re...
08-07 16:33
Autonomix Medical, Inc. Exercise of Warrants for $2.5 Million Gross Proceeds
Autonomix Medical, Inc. has entered into agreements with certain warrant holders to exercise or prepaid warrants for up to 1,477,596 shares at $1.723 per share, generating approximately $2.5 million in gross proceeds. New unregistered warrants will be issued, exercisable for the same number of shares at the same price, valid for five and a half years. The transaction is expected to close on July 23, 2025, with proceeds used for working capital an...
07-22 12:30
Amicus Therapeutics to Announce Second Quarter 2025 Financial Results on July 31, 2025
Amicus Therapeutics will host a conference call and live audio webcast on July 31, 2025, at 8:30 a.m. ET to discuss Q2 2025 financial results. Participants must register online to receive dial-in details, while webcast access is available via the company's Investor Relations website. An archived webcast and slides will be posted shortly after the event.
07-21 11:00
Aemetis appoints CFO of India subsidiary Universal Biofuels
Aemetis (NASDAQ:AMTX) announced Anjaneyulu Ganji as chief financial officer of its India subsidiary, Universal Biofuels, effective July 17, 2025. Ganji's experiences include leading Dodla Dairy’s $450...
07-17 20:19
Aemetis India Appoints Chief Financial Officer
Aemetis subsidiary Universal Biofuels appoints Anjaneyulu Ganji as Chief Financial Officer to lead expansion in India, focusing on biodiesel, ethanol, and renewable natural gas production. Ganji brings extensive expertise from roles at Dodla Dairy, Marengo Asia Healthcare, and Maersk. Universal Biofuels operates an 80 million gallon biodiesel facility in India and is expanding its biofuels production. Aemetis, based in California, specializes in ...
07-17 12:00
Aemetis CEO to Present at H.C. Wainwright 27th Annual Global Investment Conference
Aemetis CEO Eric McAfee will present at the H.C. Wainwright Annual Global Investment Conference in New York City on September 8-10, 2025. The company highlights its growth projects, including renewable natural gas production, ethanol plant upgrades, carbon sequestration, and a renewable diesel plant. Aemetis benefits from federal and state policies supporting biogas and biofuels, including the One Big Beautiful Bill and California's Low Carbon Fu...
07-16 12:00
